---
figid: PMC7348626__f85-03-9780323430449
figtitle: COX-2/TxA2 pathway is a crucial mechanism underlying the toxicity reducing
  and efficacy enhancing effects of glycyrrhizin (GL) and glycyrrhetinic acid (GA)
  to NSAIDs/DMARDs
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC7348626
filename: f85-03-9780323430449.jpg
figlink: pmc/articles/PMC7348626/figure/f0020/
number: F85
caption: The COX-2/TxA2 pathway is a crucial mechanism underlying the toxicity reducing
  and efficacy enhancing effects of glycyrrhizin (GL) and glycyrrhetinic acid (GA)
  to NSAIDs/DMARDs. TNF, Tumor necrosis factor; IL, interleukin; RA FLS, rheumatoid
  arthritis fibroblast-like synoviocytes; COX, cyclooxygenase; TxA2, thromboxane A2;
  TP, thromboxane A2 receptor; PGH2, prostaglandin H2; PGE2, prostaglandin E2; NSAIDs,
  nonsteroidal anti-inflammatory drugs; DMARDs, disease modifying antirheumatic drugs;
  NF-κB, nuclear factor κB; CREB, cAMP response element-binding protein; MAPKs, mitogen
  activated protein kinases; PI3K, phosphoinositide-3-kinase; VEGF, vascular endothelial
  growth factor; ACTN1, α-actinin-1; MMPs, matrix metalloproteinase.
papertitle: Glycyrrhiza glabra (Licorice).
reftext: Michael T. Murray. Textbook of Natural Medicine. 2020 :641-647.e3.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6751384
figid_alias: PMC7348626__F85
figtype: Figure
redirect_from: /figures/PMC7348626__F85
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7348626__f85-03-9780323430449.html
  '@type': Dataset
  description: The COX-2/TxA2 pathway is a crucial mechanism underlying the toxicity
    reducing and efficacy enhancing effects of glycyrrhizin (GL) and glycyrrhetinic
    acid (GA) to NSAIDs/DMARDs. TNF, Tumor necrosis factor; IL, interleukin; RA FLS,
    rheumatoid arthritis fibroblast-like synoviocytes; COX, cyclooxygenase; TxA2,
    thromboxane A2; TP, thromboxane A2 receptor; PGH2, prostaglandin H2; PGE2, prostaglandin
    E2; NSAIDs, nonsteroidal anti-inflammatory drugs; DMARDs, disease modifying antirheumatic
    drugs; NF-κB, nuclear factor κB; CREB, cAMP response element-binding protein;
    MAPKs, mitogen activated protein kinases; PI3K, phosphoinositide-3-kinase; VEGF,
    vascular endothelial growth factor; ACTN1, α-actinin-1; MMPs, matrix metalloproteinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - COX2
  - tnfb
  - il1b
  - itpka
  - actn1
  - vegfaa
  - il6
  - PTGS2
  - TNF
  - IL1B
  - IL17A
  - ITPKB
  - AKT1
  - PTK2B
  - TBXAS1
  - ACTN1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - NFKB1
  - IL6
  - IL18
  - Glycyrrhizin
  - Glycyrrhetinic acid
  - PGE2
  - TXA2
  - RA
---
